Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Visual field defect
ADR ID BADD_A04594
ADR Hierarchy
06      Eye disorders
06.02      Vision disorders
06.02.07      Visual field disorders
06.02.07.003      Visual field defect
17      Nervous system disorders
17.17      Neurological disorders of the eye
17.17.01      Neurologic visual problems NEC
17.17.01.001      Visual field defect
Description A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions. | A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA), OPTIC NERVE DISEASES, and other conditions. [MeSH]
MedDRA Code 10047555
MeSH ID D012607
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Arcuate scotoma | Blind spot enlarged | Central scotoma | Defect visual field (NOS) | Generalized visual field contraction or constriction | Mariotte's spot enlarged | Other localized visual field defect | Peripheral vision defective | Scotoma | Scotoma annular | Scotoma central | Scotoma involving central area | Scotoma of blind spot area | Scotoma peripheral | Scotoma transient | Sector or arcuate visual field defects | Vision central defective | Vision peripheral decreased | Vision peripheral defective | Visual field constriction | Visual field defect | Visual field defect NOS | Visual field defect, unspecified | Visual field defects | Bilateral visual field constriction | Scotomas | Scotoma, Arcuate | Arcuate Scotoma | Arcuate Scotomas | Scotomas, Arcuate | Scotoma, Bjerrum | Bjerrum Scotoma | Bjerrum Scotomas | Scotomas, Bjerrum | Scotoma, Central | Central Scotoma | Central Scotomas | Scotomas, Central | Scotoma, Sector | Scotomas, Sector | Sector Scotoma | Sector Scotomas | Scotoma, Paracecal | Paracecal Scotoma | Paracecal Scotomas | Scotomas, Paracecal | Scotoma, Paracentral | Paracentral Scotoma | Paracentral Scotomas | Scotomas, Paracentral | Scotoma, Peripheral | Peripheral Scotoma | Peripheral Scotomas | Scotomas, Peripheral | Scotoma, Ring | Ring Scotoma | Ring Scotomas | Scotomas, Ring | Scotoma, Scintillating | Scintillating Scotoma | Scintillating Scotomas | Scotomas, Scintillating | Scotoma, Altitudinal | Altitudinal Scotoma | Altitudinal Scotomas | Scotomas, Altitudinal | Scotoma, Centrocecal | Centrocecal Scotoma | Centrocecal Scotomas | Scotomas, Centrocecal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01508Mycophenolic acid--
BADD_D01510Nabilone--
BADD_D01533Naproxen--
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01558Nexium--
BADD_D01567Nilotinib0.000358%
BADD_D01633Oxaliplatin0.000336%
BADD_D01637Oxcarbazepine--
BADD_D01653Paclitaxel--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01731Pentoxifylline--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01765Phenytoin--
BADD_D01771Pilocarpine hydrochloride0.009062%
BADD_D01804Posaconazole--
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01831Prednisolone0.000070%
BADD_D01834Prednisone0.000036%
BADD_D01835Pregabalin0.000711%
BADD_D01888Quetiapine0.000082%
BADD_D01893Quinidine gluconate--
The 5th Page    First    Pre   5 6 7 8    Next   Last    Total 8 Pages